Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>News>This Article

Biologics Introduces Clinical Policy and Therapeutic Intelligence Office

Published: Wednesday, May 01, 2013
Last Updated: Wednesday, May 01, 2013
Bookmark and Share
Biologics is pleased to announce the launch of its Clinical Policy and Therapeutic Intelligence Office.

The department has been established to advance the company’s clinical expertise efforts as it continues to distinguish itself as a leader in complex disease medical management and pharmacy services, specifically within the oncology sector. Leading this initiative will be Ann Steagall, BSN, RN, OCN, Director of Clinical Policy and Mike James, RPh, PhD, Director of Therapeutic Intelligence.
Primary objectives for the department will be to lead the clinical oversight committee, develop care plans and clinical assessments, and facilitate training for clinical and non-clinical Biologics team members and clients.

“Over the years we have discussed the importance of Biologics leading with our clinical expertise both internally and externally. Additionally, it has long been our objective for Biologics to be considered a teaching organization,” said Stuart Frantz, President & Chief Executive Officer at Biologics. “Combine those two concepts and you have the Clinical Policy and Therapeutic Intelligence Office.”

As Director of Clinical Policy, Ann will lead the coordination of all plan language reviews, an important component of the Care Integration program. She will also continue to serve on the Oncology Board of Advisors.

As Director of Therapeutic Intelligence, Mike will assess all new drug entries and expanded uses which include pipeline monitoring. He will support the development of disease specific whitepapers for client and internal education, and will serve on the Oncology Board of Advisors.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Researchers Develop Classification Model for Cancers Caused by KRAS
Most frequently mutated cancer gene help oncologists choose more effective cancer therapies.
Tolerant Immune System Increases Cancer Risk
Researchers have found that individuals with high immunoCRIT ratios may have an increased risk of developing certain cancers.
Developing a Gel that Mimics Human Breast for Cancer Research
Scientists at the Universities of Manchester and Nottingham have been funded to develop a gel that will match many of the biological structures of human breast tissue, to advance cancer research and reduce animal testing.
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
Editing Genes to Create HIV Killers
Seattle scientists have managed to genetically transform human cells in the lab from HIV targets to HIV killers, and the technique could have implications for cancer and other diseases.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos